Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Regents of the University of Colorado”

401 pharma patents match "The Regents of the University of Colorado" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 401
Index total 30,257
Page 11 / 17

Quick answer

This filtered view shows 401 pharmaceutical patents matching "The Regents of the University of Colorado" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

401 results for “The Regents of the University of Colorado” · 30,257 patents in full index Clear search

  1. US 9180196

    Photodegradable groups for tunable polymeric materials

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  2. US 9150831

    Conditionally immortalized long-term stem cells and methods of making and using such cells

    The Regents of the University of Colorado · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted

  3. US 9144608

    Method for stimulating retinal response using photoactive devices

    The Regents of the University of Colorado · Granted Sep 29, 2015 · Expires Sep 24, 2035

    granted

  4. US 9138383

    Nanogel materials and methods of use thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 22, 2015 · Expires Sep 17, 2035

    granted

  5. US 9095608

    Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD40 antibody

    The Regents of the University of Colorado · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  6. US 9091701

    Disease severity index for assessment of chronic liver disease and method for diagnosis of three distinct subtypes of primary sclerosing cholangitis

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 28, 2015 · Expires Jul 23, 2035

    granted

  7. US 9084746

    Therapeutic applications of SMAD7

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 21, 2015 · Expires Jul 16, 2035

    granted

  8. US 9073985

    Methods and products for treating proliferative diseases

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 7, 2015 · Expires Jul 2, 2035

    granted

  9. US 9067968

    Tight junction protein modulators and uses thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Jun 30, 2015 · Expires Jun 25, 2035

    granted

  10. US 9066943

    Use of botulinum toxin therapy for treatment of urological neurological conditions

    The Regents of the University of Colorado · Granted Jun 30, 2015 · Expires Jun 25, 2035

    granted

  11. US 9067961

    Thiocarbon-protecting groups for RNA synthesis

    The Regents of the University of Colorado Denver · Granted Jun 30, 2015 · Expires Jun 25, 2035

    granted

  12. US 9062347

    Endothelin single nucleotide polymorphisms and methods of predicting β-adrenergic receptor targeting agent efficacy

    The Regents of the University of Colorado, a Body Corporate · Granted Jun 23, 2015 · Expires Jun 18, 2035

    granted

  13. US 9045559

    Method for screening inhibitors of interleukin-32 (IL-32)

    The Regents of the University of Colorado · Granted Jun 2, 2015 · Expires May 28, 2035

    granted

  14. US 9034318

    Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria

    The Regents of the University of Colorado, a Body Corporate · Granted May 19, 2015 · Expires May 14, 2035

    granted

  15. US 9023984

    Diagnostic and therapeutic target for autoimmune diseases and uses thereof

    The Regents of the University of Colorado, a Body Corporate · Granted May 5, 2015 · Expires Apr 30, 2035

    granted

  16. US 9011844

    Human cystathionine β-synthase variants and methods of production thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  17. US 8992906

    Compositions and methods for engraftment and increasing survival of adult muscle stem cells

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 31, 2015 · Expires Mar 26, 2035

    granted

  18. US 8962530

    Inflammatory bowel disease therapies

    The Regents of the University of Colorado · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted

  19. US 8962709

    Resin systems for dental restorative materials and methods using same

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted

  20. US 8957031

    Competitive inhibitors of invariant chain expression and/or ectopic clip binding

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 17, 2015 · Expires Feb 12, 2035

    granted

  21. US 8937046

    Modulating the alternative complement pathway

    The Regents of the University of Colorado, a Body Corporate · Granted Jan 20, 2015 · Expires Jan 15, 2035

    granted

  22. US 8920799

    Methods of treating cancer by administering an Axl ligand-binding portion of an Axl tyrosine kinase receptor extracellular domain

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted

  23. US 8916603

    Methods for treatment with bucindolol based on genetic targeting

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 23, 2014 · Expires Dec 18, 2034

    granted

  24. US 8911733

    Inhibition of the alternative complement pathway for treatment of traumatic brain injury, spinal cord injury and related conditions

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.